2023-06-232023-06-232013-02Ayarcı, A. O. vd. (2013). “Diagnostic value of serum concentrations of high-mobility group-box protein 1 and soluble hemoglobin scavenger receptor in brucellosis”. Microbiology and Immunology, 57(2), 150-158.0385-56001348-0421https://doi.org/10.1111/1348-0421.12016https://onlinelibrary.wiley.com/doi/10.1111/1348-0421.12016http://hdl.handle.net/11452/33154Both cluster of differentiation (CD)4+ and CD8+ T lymphocytes play key roles in immunity to Brucella, in part because they secrete interferon (IFN)- and activate bactericidal functions in macrophages. Therefore, use of markers of macrophage activation may have diagnostic and prognostic significance. High-mobility group-box 1 protein (HMGB1), a late-onset pro-inflammatory cytokine, is secreted by activated macrophages. Soluble hemoglobin scavenger receptor (sCD163) is a specific marker of anti-inflammatory macrophages. The aim of this study was to investigate the diagnostic value of HMGB1 and sCD163 concentrations in brucellosis and its various clinical forms. Serum HMGB1 and sCD163 concentrations in 49 brucellosis patients were compared with those in 52 healthy control subjects. Both serum HMGB1 and sCD163 concentrations were significantly higher in brucellosis patients than in healthy controls (P<0.001). There were no statistically significant differences in serum concentrations of HMGB1 and sCD163 between cases of acute, subacute and chronic brucellosis. Additionally, serum HMGB1 concentrations were positively correlated with sCD163 concentrations, whereas neither HMGB1 nor sCD163 concentrations were correlated with C-reactive protein concentrations, white cell counts or erythrocyte sedimentation rates. Therefore, serum concentrations of HMGB1 and sCD163 may be diagnostic markers for brucellosis, but neither can be used to differentiate the three different forms of this disease (acute, subacute and chronic).eninfo:eu-repo/semantics/openAccessImmunologyMicrobiologyBrucellaHigh-mobility group-box 1 proteinImmunitySoluble hemoglobin scavenger receptorCommunity-acquired infectionsLipopolysaccharide-binding proteinAlternative activationLate mediatorCD163 levelsHMGB1BacteremiaMarkersChildrenSepsisAdultAgedAntigens, CDAntigens, differentiation, myelomonocyticBiological markersBlood sedimentationBrucellaBrucellosisC-reactive proteinFemaleHMGB1 proteinHumansLeukocyte countMaleMiddle agedReceptors, cell surfaceSerumArticle0003149841000102-s2.0-8487373210115015857223278480ImmunologyMicrobiologyMacrophage; Macrophage Activation; Haptoglobin-Hemoglobin ComplexC reactive proteinCD163 antigenHigh mobility group B1 proteinAdultArticleBlood samplingBrucellaBrucellosisClinical articleClinical featureControlled studyCorrelation analysisDiagnostic test accuracy studyDiagnostic valueDifferential diagnosisDisease markerDisease severityErythrocyte sedimentation rateFemaleHumanHuman cellLeukocyte countMaleNephelometryProtein analysisProtein blood levelProtein functionReceiver operating characteristicReference valueSensitivity and specificitySymptomatology